Streetbeat News

Products Services

PBM

Psyence Biomed Ltd. (NASDAQ:PBM) announced the export of nature-derived psilocybin to Australia and provided an update on its upcoming Phase IIb clinical trial for treating Adjustment Disorder in palliative care. The trial will start shortly after the drug product is received by trial sites.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 8:14 pm

Ford has updated its full-year EBIT outlook, raising expectations for Ford Pro to $9.0 billion to $10.0 billion due to growth and favorable product mix, while lowering expectations for Ford Blue to $6.0 billion to $6.5 billion due to higher than planned warranty costs.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 8:12 pm

CMG

Chipotle Mexican Grill (CMG) has provided its outlook for FY24, expecting comparable restaurant sales growth in the mid to high-single digit range, 285-315 new restaurant openings with over 80% featuring a ChipotLane, and an estimated underlying effective full year tax rate between 25%-27% before discrete items.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 8:12 pm

CRWD

DAL

MAR

MSFT

UAL

CrowdStrike Holdings Inc (CRWD) admitted that a bug in its safety mechanism caused massive global IT outages, affecting Microsoft Windows systems and critical operations in various industries. The incident led to a significant drop in CRWD's share price and prompted a U.S. House Committee inquiry. Analyst Catharine Trebnick reiterated a Buy rating but lowered the price target due to expected short-term repercussions.

Portfolio Pulse from Shivani Kumaresan

July 24, 2024 | 8:12 pm

HMC

Honda is planning to reduce its production capacity for gasoline cars in China by 30%, according to a report by Nikkei. This move is part of Honda's strategy to shift focus towards electric vehicles (EVs) and adapt to changing market demands.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 8:02 pm

ALGN

Align Technology has introduced the iTero Design Suite, which allows for in-practice 3D printing of models, bite splints, and restorations. Early access registration opens today, with availability to customers later this year.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 8:01 pm

GOOG

GOOGL

Alphabet Inc's Google Play Store is introducing new features to enhance user experience, including a 'Collections' section, improved gaming functionalities, expanded rewards, and a curated comics section in Japan. These updates aim to provide better content organization, personalized recommendations, and exclusive rewards.

Portfolio Pulse from Franca Quarneti

July 24, 2024 | 7:46 pm

NVS

Novartis lost a ruling from the FDA, which allows for the production of a generic version of its drug Ernestro. This could impact Novartis' market share and revenue from this drug.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 7:44 pm

MUX

STLA

Robert McEwen, a prominent mining executive, discusses his journey in the mining industry, his innovative approaches, and his current ventures with McEwen Mining (NYSE:MUX) and McEwen Copper. He highlights the importance of understanding cyclicality and seasonality in commodity prices and mentions the significant role of copper in modern technologies, with Stellantis (NYSE:STLA) being a major shareholder in McEwen Copper's Los Azules project.

Portfolio Pulse from Stjepan Kalinic

July 24, 2024 | 7:23 pm

ALMS

BMY

JNJ

TAK

Alumis Inc. (NASDAQ: ALMS), a clinical-stage biopharmaceutical company, has attracted attention from analysts at Guggenheim Partners and Cantor Fitzgerald. Both firms initiated coverage with positive ratings, citing the potential of Alumis' lead asset ESK-001 and its brain-penetrant TYK2 inhibitor A-005. Guggenheim set a price target of $32, while Cantor highlighted the company's modest valuation and commercial potential. Alumis recently raised $250 million through its IPO and private placement.

Portfolio Pulse from Vandana Singh

July 24, 2024 | 7:18 pm